Literature DB >> 8871344

TCR usage in human and experimental demyelinating disease.

D A Hafler1, M G Saadeh, V K Kuchroo, E Milford, L Steinman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8871344     DOI： 10.1016/0167-5699(96)80611-6

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  22 in total

Review 1.  T cell receptor usage in autoimmune disease.

Authors:  P Moss; J Bell
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Oligoclonal T cell repertoire in cerebrospinal fluid of patients with inflammatory diseases of the nervous system.

Authors:  D Gestri; L Baldacci; R Taiuti; E Galli; E Maggi; M P Piccinni; M Vergelli; L Massacesi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

Review 3.  Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.

Authors:  Reinhard Hohlfeld; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-11       Impact factor: 11.205

4.  Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms.

Authors:  D A Duszczyszyn; J D Beck; J Antel; A Bar-Or; Y Lapierre; V Gadag; D G Haegert
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

5.  Expansion of a recurrent V beta 5.3+ T-cell population in newly diagnosed and untreated HLA-DR2 multiple sclerosis patients.

Authors:  P Musette; D Bequet; C Delarbre; G Gachelin; P Kourilsky; D Dormont
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

6.  Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking.

Authors:  R Aharoni; D Teitelbaum; R Arnon; M Sela
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

7.  Oligoclonal populations of T and B cells in a case of angioimmunoblastic T-cell lymphoma predominantly infiltrated by T cells of the VB5.1 family.

Authors:  E Hodges; C T Quin; D H Wright; J L Smith
Journal:  Mol Pathol       Date:  1997-02

8.  Prevention and treatment of experimental autoimmune encephalomyelitis with clonotypic CDR3 peptides: CD4(+) Foxp3(+) T-regulatory cells suppress interleukin-2-dependent expansion of myelin basic protein-specific T cells.

Authors:  Abigail C Buenafe; Shayne Andrew; Michael Afentoulis; Halina Offner; Arthur A Vandenbark
Journal:  Immunology       Date:  2010-01-06       Impact factor: 7.397

Review 9.  Vaccines for multiple sclerosis: progress to date.

Authors:  Jorge Correale; Mauricio Farez; Wendy Gilmore
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 10.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.